Hang Xu

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index10.5kcitations186works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(43), Bladder and Urothelial Cancer Treatments(21), Melanoma and MAPK Pathways(19), Cancer Immunotherapy and Biomarkers(18), Renal cell carcinoma treatment(17)

Publications186 total

PANX1-mediated NLRP3 inflammasome activation promotes an adaptive doxorubicin resistance through IL-1β signaling in breast cancer.
Cancer Letters·2026
Constructing a machine learning model for predicting early postoperative recurrence of pancreatic head cancer based on a novel inflammatory factor composite index
BMC Cancer·2025Open Access
Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
2025Open Access
Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways
2025Open Access
Gut microbial metabolites in cancer immunomodulation
Molecular Cancer·2025· 2 citedOpen Access
Decoding GDF15: Impact on prostate cancer metabolism, chemoresistance, and clinical applications
Chinese Medical Journal·2025Open Access
Abbreviated biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis
International Journal of Surgery·2025Open Access
Liquid–Liquid Phase Separation of AR Orchestrated by Melatonin Sensitizes Prostate Cancer to Ferroptosis Via MCM5/NRF2 Axis Collapse
Journal of Pineal Research·2025
Regional Transcriptomic Architecture of Glioblastoma Reveals <scp>NUCB2</scp> as a Key Orchestrator of Tumour Aggression and Immune Dysfunction
Journal of Cellular and Molecular Medicine·2025Open Access
Operationalizing intermediate clinical endpoints: A pragmatic framework for prostate cancer management trials
Cancer Treatment Reviews·2025
Multiplex one-step RT‒qPCR assays for simultaneous detection of AMDV, MEV and CDV
BMC Veterinary Research·2025· 5 citedOpen Access
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling
Nature Cell Biology·2024· 7 citedOpen Access
Engineering Dual Active Sites and Defect Structure in Nanozymes to Reprogram Jawbone Microenvironment for Osteoradionecrosis Therapy
Advanced Science·2024· 14 citedOpen Access
Genome-wide identification and characterization of BASIC PENTACYSTEINE transcription factors and their binding motifs in coconut palm
Frontiers in Plant Science·2024· 5 citedOpen Access
Global incidence and trends of ocular cancer: A bibliometric analysis
Advances in Ophthalmology Practice and Research·2024· 3 citedOpen Access
Bioengineering for robust tolerance against cold and drought stresses via co-overexpressing three Cu-miRNAs in major food crops
Cell Reports·2024· 14 citedOpen Access
Data from Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
2024Open Access
Supplementary Tables S1-S8 from Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
2024Open Access
Supplementary Figures S1-S25 from Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
2024Open Access
Supplementary Figures S1-S25 from Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
2024Open Access
page 1 of 10Next →

Frequent Co-authors

Samra Turajlic(16), Charles Swanton(16), Andrew Rowan(14), Stuart Horswell(12), Kevin Litchfield(12), James Larkin(12), Nicholas McGranahan(11), Jianzhong Ai(11), Sergio A. Quezada(10), Lewis Au(10), Lisa Pickering(10), Mariam Jamal‐Hanjani(9), Sophia Ward(9), Steve Hazell(9), Lavinia Spain(9), Nicolai J. Birkbak(8), Mary Falzon(8), Teresa Marafioti(8), David Nicol(8), Qiang Wei(8)